Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-074463

Chief Operating Officer sold 100,000 shares

  • Chief Operating Officer acquired 100,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kling Douglas F · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-05-15 Exercise or conversion : show line 1 in the form 10b5-1 +100,000 $10.00 $1,000,000 144,000 D
2025-05-15 Sale : show line 2 in the form 10b5-1 −100,000 44,000 D
Open-market sales · 100,000 sh

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-05-15 Exercise or conversion : show line 3 in the form 10b5-1 Option (right to buy) −100,000 450,930 D
Loading xslF345X05/ownership.xml…